Journal List > Korean J Hepatobiliary Pancreat Surg > v.16(3) > 1040577

Kim and Choi: Long-term survival after resection of hepatocellular carcinoma

Abstract

Backgrounds/Aims

Although recent advances in surgical techniques and alternative treatment, the long-term survival >5 years after liver resection for hepatocellular carcinoma (HCC) is still unsatisfactory due to the high recurrence rate compared with other solid organ cancers. This study was conducted to analyze long-term survival after HCC resection and to develop an optimal strategy to achieve long-term survival.

Methods

A retrospective review was performed for HCC patients who underwent liver resection between 1996 and 2006. The survival rates and prognostic factors were assessed. The clinical and pathological factors of patients who survived more than 5 years were compared with those of patients whose survival was less than 5 years. The clinicopathological features characterizing long-term survivors were also reviewed.

Results

The overall and disease-free 5-year survival rates of 87 cases were 38.5% and 29.4%, respectively. Twenty-seven of 87 patients survived longer than 5 years after liver resection. The univariate analysis revealed that hepatitis C, the serum aspartate sminotransferase (AST) level, liver cirrhosis, Edmondson-Steiner grade, AJCC stage, and vascular invasion were significant factors for overall survival, and serum AST level, liver cirrhosis, Edmondson-Steiner grade, AJCC stage, and vascular invasion were the affecting factors for disease-free survival. In multivariate analysis, serum AST level, hepatitis C and vascular invasion were related with the overall survival, liver cirrhosis and vascular invasion which were associated with disease-free survival. Vascular invasion, AJCC stage, and the Edmondson-Steiner grade were significant factors in long-term survivors.

Conclusions

Patients without liver cirrhosis, vascular invasion and normal liver function, good differentiation and an early stage may be expected to have a long-term survival.

Figures and Tables

Table 1
The characteristics of 87 patients who received hepatic resections
kjhbps-16-98-i001

HBV, hepatitis B virus; HCV, hepatitis C virus; ICG, indocyanin green; AST, aspartate aminotransferase; ALT, alanine aminotransferase

Table 2
Univariate analysis of prognostic factors, overall survival and disease-free survival after a hepatic resection (n=87)
kjhbps-16-98-i002

AST, aspartate aminotransferase; ALT, alanine aminotransferase; AFP, alpha-fetoprotein; ICG, indocyanin green

Table 3
Multivariate analysis of the overall and disease-free survival after hepatic resection (n=87)
kjhbps-16-98-i003

AST, aspartate aminotransferase

Table 4
Patterns of recurrence
kjhbps-16-98-i004
Table 5
Treatments of recurrence
kjhbps-16-98-i005

TACE, transarterial chemoembolization; RFA, radiofrequency ablation

Table 6
Comparison of the clinicopathologic variables between the long-term (L-group) and short-term (S-group) survivors after surgical resection for hepatocellular carcinoma
kjhbps-16-98-i006

HBV, hepatitis B virus; HCV, hepatitis C virus; ICG, indocyanin green; AST, aspartate aminotransferase; ALT, alanine aminotransferase

ACKNOWLEDGEMENTS

This research was supported by grant of Inje University (2010).

References

1. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993. 105:488–494.
2. Roh MJ, Kim HJ, Yoon SS, et al. Longterm prognostic factors after hepatic resection for hepatocellular carcinoma. J Korean Surg Soc. 2009. 76:225–230.
3. Ibrahim S, Roychowdhury A, Hean TK. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Am J Surg. 2007. 194:17–22.
4. Nagasue N, Ono T, Yamanoi A, et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg. 2001. 88:515–522.
5. Marelli L, Stigliano R, Triantos C, et al. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev. 2006. 32:594–606.
6. Cho HW, Lee JG, Lim CY, et al. Factors affecting the recurrence of hepatocellular carcinoma after surgical resection. J Korean Surg Soc. 2005. 69:465–470.
7. Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 2007. 141:330–339.
8. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 2010. 7th ed. Chicago: Springer.
9. Kalayci C, Johnson PJ, Davies SE, et al. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol. 1991. 12:54–59.
10. el-Refaie A, Savage K, Bhattacharya S, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol. 1996. 24:277–285.
11. Chen MF, Tsai HP, Jeng LB, et al. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg. 2003. 27:443–447.
12. Fuster J, García-Valdecasas JC, Grande L, et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg. 1996. 223:297–302.
13. Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006. 202:275–283.
14. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993. 328:1797–1801.
15. Lee KU, Koh YT, Kim KH, et al. Prognostic factors of hepatocellular carcinoma after curative hepatic resection. Korean J Hepatobiliary Pancreat Surg. 1997. 1:41–58.
16. Laurent C, Blanc JF, Nobili S, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg. 2005. 201:656–662.
17. Fan ST, Ng IO, Poon RT, et al. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg. 1999. 134:1124–1130.
18. Han SH, Lee WJ, Noh SH, et al. Univariate and multivariate analysis of prognostic factors in survival after resection of primary hepatoma. J Korean Surg Soc. 1994. 47:393–400.
19. Lee KW, Suh KS, Roh HR, et al. The effect of intraoperative transfusion on the prognosis in hepatectomized hepatocellular carcinoma patients. Korean J Hepatobiliary Pancreat Surg. 2000. 4:77–83.
20. Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994. 115:303–309.
21. Matsumata T, Ikeda Y, Hayashi H, et al. The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer. 1993. 72:1866–1871.
22. Cha C, Fong Y, Jarnagin WR, et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg. 2003. 197:753–758.
23. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000. 232:10–24.
24. Poon RT, Fan ST, Lo CM, et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg. 1999. 229:216–222.
TOOLS
Similar articles